Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations.

Acta neuropathologica - 1 Feb 2021

Schüller Ulrich, Iglauer Peter, Dorostkar Mario M, Mawrin Christian, Herms Jochen, Giese Armin, Glatzel Markus, Neumann Julia E

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Brain Neoplasms
Share to Genes, ras
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histones

Share to Prognosis

Share to Receptor, Fibroblast Growth Factor, Type 1

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 33433639
DOI: 10.1007/s00401-020-02259-y
PMCID: PMC7847449

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations.PMID 33433639Read ↗

Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.Semantic proximity Read ↗

Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma.Semantic proximity Read ↗

H3K27-altered diffuse midline gliomas with MAPK pathway alterations: Prognostic and therapeutic implications.Semantic proximity Read ↗

Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant.Semantic proximity Read ↗

H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients.Semantic proximity Read ↗

A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.Semantic proximity Read ↗

H3K27M-mutant Diffuse Midline Gliomas should be Further Molecularly Stratified: An Integrated Analysis of 669 PatientsSemantic proximity Read ↗

FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas.Semantic proximity Read ↗

Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adultsSemantic proximity Read ↗

Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.Semantic proximity Read ↗

H3G34-Mutant Gliomas—A Review of Molecular Pathogenesis and Therapeutic OptionsSemantic proximity Read ↗

Diffuse Midline Gliomas without the H3 K27M Mutation: Surgical Biopsy is Needed to Better our Diagnostic Understanding.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.